Tinna Kwan
Sr. Director, Clinical Operations at 89bio- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
89bio
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Sr. Director, Clinical Operations
-
Apr 2021 - Present
-
-
-
Intercept Pharmaceuticals
-
United States
-
Pharmaceutical Manufacturing
-
300 - 400 Employee
-
Sr. Director, Clinical Operations
-
May 2019 - Sep 2021
-
-
-
Nestlé Health Science
-
Switzerland
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Head of Clinical Operations Americas
-
Sep 2017 - Apr 2019
-
-
-
Avanir Pharmaceuticals
-
United States
-
Pharmaceutical Manufacturing
-
100 - 200 Employee
-
Sr. Director, Clinical Research
-
Apr 2016 - Sep 2017
-
-
-
Acadia Pharmaceuticals Inc.
-
United States
-
Pharmaceutical Manufacturing
-
400 - 500 Employee
-
Director Clinical Operations
-
Aug 2015 - Apr 2016
-
-
-
Allergan
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Director, Clinical Development
-
Feb 2014 - Jun 2015
Directed multiple Clinical programs including adult and pediatric spasticity and migraine headache serving the role of Clinical Lead and/or Clinical Scientist.
-
-
Sr. Clinical Manager
-
Mar 2010 - Feb 2014
Developed and led multiple Clinical programs including adult and pediatric spasticity serving the role of Clinical Lead and/or Clinical Scientist.
-
-
Country Representation And Operations Specialist
-
Feb 2009 - Mar 2010
Successfully connected operations units in Asia and the study teams at Headquarters to close gaps in communication and processes which led to improved trial experience in the region.
-
-
Clinical Project Manager, Clinical Study Manager, Principal CRA
-
2002 - Feb 2009
Managed multiple trials from single-site Phase I to global pivotal Phase III studies in glaucoma, retina diseases and neuropathic pain.
-
-
-
Cancer International Research Group
-
Los Angeles, CA
-
Regional CRA
-
2001 - 2002
Initiated, monitored and closed out sites for 3 concurrent breast cancer trials. Trained new CRAs and prepared presentations at the Annual Conference. Initiated, monitored and closed out sites for 3 concurrent breast cancer trials. Trained new CRAs and prepared presentations at the Annual Conference.
-
-
-
Alpha Therapeutic Corp
-
United States
-
Biotechnology
-
1 - 100 Employee
-
In-House CRA
-
1996 - 1998
-
-
In-House CRA
-
1996 - 1998
-
-
Education
-
University of Arizona
Ph.D., Nursing